Serotonergic Antidepressants in Obsessive-Compulsive Personality Disorder

This chapter contains sections titled: Introduction Antidepressant or Antiobsessional? Clomipramine (CMI) Selective Serotonin Reuptake Inhibitors (SSRIs) Drug Dosage Side Effects of Antiobsessional Medications Onset of Treatment Response Long-term Approach Special Conditions Treatment-resistant OCD Summary References This chapter also contains the following commentaries: Pharmacotherapy of Obsessive-compulsive Disorder: Accomplishment, Unanswered Questions and New Directions. Authored by Teresa A. Pigott Beyond Serotonin Reuptake Inhibitors: Do We Have Our Second Wind? Authored by Christopher J. McDougle Future Pharmacotherapy for Obsessive-compulsive Disorder: 5-HT2 Agonists and Beyond. Authored by Pedro L. Delgado Comments on the Pharmacological Treatment of Obsessive-compulsive Disorder. Authored by Matig R. Mavissakalian The Expanding Obsessive-compulsive Disorder Evidence Base. Authored by Lorrin M. Koran The Heterogeneity of Obsessive-compulsive Disorder and Its Implications for Treatment. Authored by Laura Bellodi Pharmacotherapy of Obsessive-compulsive Disorder: Questions for the Next Decade. Authored by Mihaly Arato Recent Progress and Open Issues in the Pharmacological Approach to Obsessive-compulsive Disorder. Authored by José A. Yaryura-Tobias Treatment and Neurobiology of Obsessive-compulsive Disorder. Authored by Johan A. den Boer Obsessive-compulsive Disorder: Pharmacological Decision. Authored by Jambur Ananth Serotonergic Antidepressants in Obsessive-compulsive Personality Disorder. Authored by M. Ansseau Drug Treatment of Obsessive-compulsive Disorder: Dark Past, Bright Present, but Glowing Future.